KM
Kenneth Allen Myszkowski (Chief Financial Officer) filed 1 Form 4 report in the past 24 months (0 purchases, 1 sale), most often in Arrowhead Pharmaceuticals, Inc. (ARWR). The largest single filing was $893K of ARWR (45,167 sh across 4 lots, as filed), executed Jan 6 2025. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$893K
shares × price, as filed
Last traded
Jan 7 2025
Filed Jan 7 2025
Median ADV $181.7M across their filed names
Open performance→Volume by month
Buys $0
Sells $893K
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 24 months
Most traded names
ARWRRecent filings
ARWRSALE
Arrowhead Pharmaceuticals, Inc.
View filing →
$893K45,167 sh across 4 lots
Exec Jan 6 2025
Filed Jan 7 2025 · 5:30 PM ET